相关实验视频

Updated: Jun 29, 2025

Direct Measurement of KDM1A Target Engagement Using Chemoprobe-based Immunoassays

Direct Measurement of KDM1A Target Engagement Using Chemoprobe-based Immunoassays

Published on: June 13, 2019

规范新疗法LSD1的策略

Meng Li¹, Mengge Dai¹, Bing Cheng¹

¹School of Pharmaceutical Sciences & Key Laboratory of Advanced Drug Preparation Technologies, Ministry of Education, Zhengzhou University, Zhengzhou 450001, China.

Acta pharmaceutica Sinica. B

|April 4, 2024

概括

氨酸特异性去甲基酶1 (LSD1) 调节基因转录,是疾病的点. 本综述详细介绍了蛋白质,翻译后修改和代谢物如何动态调节LSD1活动.

科学领域:

表观遗传学在表观遗传学中,表观遗传学是指表观遗传学.
分子生物学分子生物学
生物化学生物化学

背景情况:

基因组甲基化是染色质结构和基因转录的关键.
氨酸特异性去甲基酶1 (LSD1) 在疾病中过度表达,是治疗点.
LSD1通过从H3K4和H3K9.9中去除甲基组来调节基因转录.

研究的目的:

系统地审查LSD1活动的监管因素.
探索转录核心压缩机复合体如何影响LSD1.1.
总结翻译后修改和代谢物对LSD的影响1.1.

主要方法:

对LSD1调节研究的文献综述.
在核心压缩机复合体内对蛋白相互作用的分析.
对LSD的翻译后修改和代谢物影响的检查1.1.

主要成果:

LSD1活动是由除去甲基酶功能之外的多个因素动态调节的.
形成转录核心压缩复合体的蛋白质调节LSD1.1.
翻译后的修改和细胞代谢物也影响LSD1的表达和活性.

结论:

了解LSD1调节对于开发向疗法至关重要.
LSD1的复杂调节网络涉及蛋白质相互作用,PTM和代谢物.
对这些调控机制的进一步研究可以揭示LSD1相关疾病的新治疗策略.

关键词:

这是LSD1规则.代谢物的代谢物.转录后的修改转录后的修改转录激活的激活方式转录压制的压制转录的压制核心压力机综合体的核心压力机.

更多相关视频

Protein WISDOM: A Workbench for In silico De novo Design of BioMolecules

Protein WISDOM: A Workbench for In silico De novo Design of BioMolecules

Published on: July 25, 2013

In Vitro Enzyme Measurement to Test Pharmacological Chaperone Responsiveness in Fabry and Pompe Disease

In Vitro Enzyme Measurement to Test Pharmacological Chaperone Responsiveness in Fabry and Pompe Disease

Published on: December 20, 2017

相关概念视频

Targets for Drug Action: Overview

Targets for Drug Action: Overview

Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...